secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001493152-23-040796
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim Q3 revenue up 34% to $27.6M, GAAP net income $527k vs loss year ago
-------------------------------------------------------------------------

- Revenue $27.6M (+34% YoY from $20.5M); GAAP net income $527k vs $1.6M loss in Q3 2022.
- Gross margin improved to 20.3% from 16.2% YoY on better product mix (XP10 smartphone).
- Cash $9.8M, debt-free; self-funds working capital and product development.
- Secured five tier-one carrier awards in North America and Australia for 5G mobile hotspots launching 2024.
- Appointed Simon Rayne as GM for UK, EMEA, and APAC sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315223040796/0001493152-23-040796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315223040796/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-040796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer